By integrating scRNA-seq and spatial transcriptomics, this study showed that the lymphoid cell niche, where T cells and B cells interact, is present even at the onset of ACPA + RA, which might help guide treatment selection in early-stage patients. The gene discussed is PRTN3; the disease is rheumatoid arthritis.